 |
 |

Transforming Growth Factor- 1 Gene Polymorphism and Bone Mineral Density
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Transforming growth factor 1 (TGF- 1) regulates bone metabolism by acting under partial control of estrogen and cooperatively with vitamin D.1-2 The Leu10 Pro polymorphism of the TGF- 1 gene is located in the signal peptide sequence,3 which is thought to target newly synthesized protein molecules to the endoplasmic reticulum. Our previous observation that the serum concentration of TGF- 1 increases with the number of C alleles suggests that the Leu10 Pro polymorphism may affect the function of the signal peptide, possibly influencing intracellular trafficking or export efficiency of the protein.4
In a previous case-control study we found that a T869 C (Leu10 Pro) polymorphism of the TGF- 1 gene is associated with reduced bone mineral density (BMD) at the lumbar spine and increased rate of bone loss in postmenopausal Japanese women. Thus, the T allele appears to represent a genetic risk factor for the development of . . . [Full Text of this Article] Methods
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Association of Polymorphisms of Interleukin-6, Osteocalcin, and Vitamin D Receptor Genes, Alone or in Combination, with Bone Mineral Density in Community-Dwelling Japanese Women and Men
Yamada et al.
J. Clin. Endocrinol. Metab. 2003;88:3372-3378.
ABSTRACT
| FULL TEXT
Analysis of transforming growth factor {beta}1 gene polymorphisms in patients with systemic sclerosis
Crilly et al.
Ann Rheum Dis 2002;61:678-681.
ABSTRACT
| FULL TEXT
|